Targeting the programmed death-1 pathway in lymphoid neoplasms

CY Ok, KH Young - Cancer treatment reviews, 2017 - Elsevier
Abstract Programmed death-1 (PD-1) is a co-inhibitory molecule and is seen in CD4+ and
CD8+ T cells. Upon binding to its ligands, programmed death ligand-1 (PD-L1) and-2 (PD …

Targeting the programmed death-1 pathway in lymphoid neoplasms

CY Ok, KH Young - Cancer treatment reviews, 2017 - pubmed.ncbi.nlm.nih.gov
Programmed death-1 (PD-1) is a co-inhibitory molecule and is seen in CD4+ and CD8+ T
cells. Upon binding to its ligands, programmed death ligand-1 (PD-L1) and-2 (PD-L2), PD-1 …

[引用][C] Targeting the programmed death-1 pathway in lymphoid neoplasms

CY Ok, KH Young - Cancer Treatment Reviews, 2017 - cir.nii.ac.jp

Targeting the programmed death-1 pathway in lymphoid neoplasms.

CY Ok, KH Young - Cancer Treatment Reviews, 2017 - europepmc.org
Abstract Programmed death-1 (PD-1) is a co-inhibitory molecule and is seen in CD4+ and
CD8+ T cells. Upon binding to its ligands, programmed death ligand-1 (PD-L1) and-2 (PD …

[HTML][HTML] Targeting the Programmed Death-1 Pathway in Lymphoid Neoplasms

CY Ok, KH Young - Cancer treatment reviews, 2017 - ncbi.nlm.nih.gov
Abstract Programmed death-1 (PD-1) is a co-inhibitory molecule and is seen in CD4+ and
CD8+ T cells. Upon binding to its ligands, programmed death ligand-1 (PD-L1) and-2 (PD …

Targeting the programmed death-1 pathway in lymphoid neoplasms

CY Ok, KH Young - Cancer Treatment Reviews, 2017 - cancertreatmentreviews.com
Abstract Programmed death-1 (PD-1) is a co-inhibitory molecule and is seen in CD4+ and
CD8+ T cells. Upon binding to its ligands, programmed death ligand-1 (PD-L1) and-2 (PD …

Targeting the programmed death-1 pathway in lymphoid neoplasms

CY Ok, KH Young - Cancer treatment reviews, 2017 - mdanderson.elsevierpure.com
Abstract Programmed death-1 (PD-1) is a co-inhibitory molecule and is seen in CD4+ and
CD8+ T cells. Upon binding to its ligands, programmed death ligand-1 (PD-L1) and-2 (PD …